|
Ang, L. P., D. T. Tan, R. W. Beuerman, and R. M. Lavker. 2004. Development of a conjunctival epithelial equivalent with improved proliferative properties using a multistep serum-free culture system. Invest Ophthalmol Vis Sci 45:1789-1795. Ang, L. P., D. T. Tan, C. J. Seah, and R. W. Beuerman. 2005. The use of human serum in supporting the in vitro and in vivo proliferation of human conjunctival epithelial cells. Br J Ophthalmol 89:748-752. Brown, S. M., and J. C. Bradley. 2005. The effect of autologous serum eye drops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 140:565; author reply 565-566. Buttke, T. M., J. A. McCubrey, and T. C. Owen. 1993. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J Immunol Methods 157:233-240. Carrington, L. M., J. Albon, I. Anderson, C. Kamma, and M. Boulton. 2006. Differential regulation of key stages in early corneal wound healing by TGF-beta isoforms and their inhibitors. Invest Ophthalmol Vis Sci 47:1886-1894. Chifflet, S., J. A. Hernandez, and S. Grasso. 2005. A possible role for membrane depolarization in epithelial wound healing. Am J Physiol Cell Physiol 288:C1420-1430. Collin, H. B., J. A. Anderson, N. R. Richard, and P. S. Binder. 1995. In vitro model for corneal wound healing; organ-cultured human corneas. Curr Eye Res 14:331-339. Esquenazi, S., J. He, H. E. Bazan, and N. G. Bazan. 2005. Use of autologous serum in corneal epithelial defects post-lamellar surgery. Cornea 24:992-997. Fox, R. I., R. Chan, J. B. Michelson, J. B. Belmont, and P. E. Michelson. 1984. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 27:459-461. Geerling, G., S. Maclennan, and D. Hartwig. 2004. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 88:1467-1474. Gieni, R. S., Y. Li, and K. T. HayGlass. 1995. Comparison of [3H]thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity. J Immunol Methods 187:85-93. Gomes, J. A., R. Amankwah, A. Powell-Richards, and H. S. Dua. 2004. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol 88:821-825. Goto, E., S. Shimmura, J. Shimazaki, and K. Tsubota. 2001. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 20:807-810. Grant, M. B., P. T. Khaw, G. S. Schultz, J. L. Adams, and R. W. Shimizu. 1992. Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis. Invest Ophthalmol Vis Sci 33:3292-3301. Grierson, I., L. Heathcote, P. Hiscott, P. Hogg, M. Briggs, and S. Hagan. 2000. Hepatocyte growth factor/scatter factor in the eye. Prog Retin Eye Res 19:779-802. Haber, M., Z. Cao, N. Panjwani, D. Bedenice, W. W. Li, and P. J. Provost. 2003. Effects of growth factors (EGF, PDGF-BB and TGF-beta 1) on cultured equine epithelial cells and keratocytes: implications for wound healing. Vet Ophthalmol 6:211-217. Hartwig, D., S. Harloff, L. Liu, P. Schlenke, T. Wedel, and G. Geerling. 2004. Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects? Transfusion 44:1724-1731. Hartwig, D., P. Herminghaus, T. Wedel, L. Liu, P. Schlenke, L. Dibbelt, and G. Geerling. 2005. Topical treatment of ocular surface defects: comparison of the epitheliotrophic capacity of fresh frozen plasma and serum on corneal epithelial cells in an in vitro cell culture model. Transfus Med 15:107-113. Hongo, M., M. Itoi, N. Yamaguchi, and J. Imanishi. 1992. Distribution of epidermal growth factor (EGF) receptors in rabbit corneal epithelial cells, keratocytes and endothelial cells, and the changes induced by transforming growth factor-beta 1. Exp Eye Res 54:9-16. Imanishi, J., K. Kamiyama, I. Iguchi, M. Kita, C. Sotozono, and S. Kinoshita. 2000. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 19:113-129. Jumblatt, M. M., and A. H. Neufeld. 1986. A tissue culture assay of corneal epithelial wound closure. Invest Ophthalmol Vis Sci 27:8-13. Kitazawa, T., S. Kinoshita, K. Fujita, K. Araki, H. Watanabe, Y. Ohashi, and R. Manabe. 1990. The mechanism of accelerated corneal epithelial healing by human epidermal growth factor. Invest Ophthalmol Vis Sci 31:1773-1778. Klenkler, B., and H. Sheardown. 2004. Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp Eye Res 79:677-688. Koizumi, N., T. Inatomi, T. Suzuki, C. Sotozono, and S. Kinoshita. 2001. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology 108:1569-1574. Kruse, F. E., and S. C. Tseng. 1993. Serum differentially modulates the clonal growth and differentiation of cultured limbal and corneal epithelium. Invest Ophthalmol Vis Sci 34:2976-2989. Lagnado, R., A. J. King, F. Donald, and H. S. Dua. 2004. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol 88:464-465. Liu, L., D. Hartwig, S. Harloff, P. Herminghaus, T. Wedel, and G. Geerling. 2005. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 243:706-714. Liu, L., D. Hartwig, S. Harloff, P. Herminghaus, T. Wedel, K. Kasper, and G. Geerling. 2006. Corneal epitheliotrophic capacity of three different blood-derived preparations. Invest Ophthalmol Vis Sci 47:2438-2444. Lu, L., P. S. Reinach, and W. W. Kao. 2001. Corneal epithelial wound healing. Exp Biol Med (Maywood) 226:653-664. Matsumoto, Y., M. Dogru, E. Goto, Y. Ohashi, T. Kojima, R. Ishida, and K. Tsubota. 2004. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 111:1115-1120. McBain, V. A., J. V. Forrester, and C. D. McCaig. 2003. HGF, MAPK, and a small physiological electric field interact during corneal epithelial cell migration. Invest Ophthalmol Vis Sci 44:540-547. McDonnell, P., D. Schanzlin, and R. NA. 1988. Immunoglobulin deposition in the corneal after application of autologous serum. Arch Ophthalmol 106:1423-1425. Moore, P. A. 2003. Diagnosis and management of chronic corneal epithelial defects (indolent corneal ulcerations). Clinical Techniques in Small Animal Practice 18:168-177. Munro, E. 2001. Advances in ocular therapeutics in dogs and cats. In Practice 23:316-327. Nakamura, M., H. Mishima, T. Nishida, and T. Otori. 1994. Binding of hyaluronan to plasma fibronectin increases the attachment of corneal epithelial cells to a fibronectin matrix. J Cell Physiol 159:415-422. Nakamura, M., and T. Nishida. 1999a. Differential effects of epidermal growth factor and interleukin 6 on corneal epithelial cells and vascular endothelial cells. Cornea 18:452-458. Nakamura, M., and T. Nishida. 1999b. Synergistic effects of hyaluronan and fibronectin on epithelial migration in rabbit cornea in vitro. Cornea 18:686-692. Nakamura, M., and T. Nishida. 2003. Potentiation by cyclic AMP of the stimulatory effect of epidermal growth factor on corneal epithelial migration. Cornea 22:355-358. Nakamura, T., L. P. Ang, H. Rigby, E. Sekiyama, T. Inatomi, C. Sotozono, N. J. Fullwood, and S. Kinoshita. 2006a. The use of autologous serum in the development of corneal and oral epithelial equivalents in patients with Stevens-Johnson syndrome. Invest Ophthalmol Vis Sci 47:909-916. Nakamura, T., T. Inatomi, C. Sotozono, L. P. Ang, N. Koizumi, N. Yokoi, and S. Kinoshita. 2006b. Transplantation of autologous serum-derived cultivated corneal epithelial equivalents for the treatment of severe ocular surface disease. Ophthalmology 113:1765-1772. Nakamura, Y., C. Sotozono, and S. Kinoshita. 2001. The epidermal growth factor receptor (EGFR): role in corneal wound healing and homeostasis. Exp Eye Res 72:511-517. Nishimura, T., S. Toda, T. Mitsumoto, S. Oono, and H. Sugihara. 1998. Effects of hepatocyte growth factor, transforming growth factor-beta1 and epidermal growth factor on bovine corneal epithelial cells under epithelial-keratocyte interaction in reconstruction culture. Exp Eye Res 66:105-116. Noda-Tsuruya, T., N. Asano-Kato, I. Toda, and K. Tsubota. 2006. Autologous serum eye drops for dry eye after LASIK. J Refract Surg 22:61-66. Ohashi, Y., M. Motokura, Y. Kinoshita, T. Mano, H. Watanabe, S. Kinoshita, R. Manabe, K. Oshiden, and C. Yanaihara. 1989. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci 30:1879-1882. Ollivier, F. J., D. E. Brooks, M. E. Kallgerg, A. M. Komaromy, M. E. Lassaline, S. E. Andrew, K. N. Gelatt, G. R. Stevens, T. D. Blalock, G. B. van Setten, and G. S. Schultz. 2003. Evaluation of various compounds to inhibit activity of matrix metalloproteinases in the tear film of horses with ulcerative keratitis. Am J Vet Res 64:1081-1087. Pellegrini, G., C. E. Traverso, A. T. Franzi, M. Zingirian, R. Cancedda, and M. De Luca. 1997. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 349:990-993. Pfister, R. R. 1992. Clinical measures to promote corneal epithelial healing. Acta Ophthalmol Suppl:73-83. Poon, A. C., G. Geerling, J. K. Dart, G. E. Fraenkel, and J. T. Daniels. 2001. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 85:1188-1197. Rama, P., S. Bonini, A. Lambiase, O. Golisano, P. Paterna, M. De Luca, and G. Pellegrini. 2001. Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation 72:1478-1485. Rheinwald, J. G., and H. Green. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331-343. Schwab, I. R., M. Reyes, and R. R. Isseroff. 2000. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. Cornea 19:421-426. Shanley, L. J., C. D. McCaig, J. V. Forrester, and M. Zhao. 2004. Insulin, not leptin, promotes in vitro cell migration to heal monolayer wounds in human corneal epithelium. Invest Ophthalmol Vis Sci 45:1088-1094. Shimmura, S., R. Ueno, Y. Matsumoto, E. Goto, A. Higuchi, J. Shimazaki, and K. Tsubota. 2003. Albumin as a tear supplement in the treatment of severe dry eye. Br J Ophthalmol 87:1279-1283. Tsai, R. J., L. M. Li, and J. K. Chen. 2000. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 343:86-93. Tsubota, K., E. Goto, H. Fujita, M. Ono, H. Inoue, I. Saito, and S. Shimmura. 1999a. Treatment of dry eye by autologous serum application in Sjogren''s syndrome. Br J Ophthalmol 83:390-395. Tsubota, K., E. Goto, S. Shimmura, and J. Shimazaki. 1999b. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106:1984-1989. Tsubota, K., and A. Higuchi. Serum application for the treatment of ocular surface disorders.113-122. Tsubota, K., Y. Satake, M. Ohyama, I. Toda, Y. Takano, M. Ono, N. Shinozaki, and J. Shimazaki. 1996. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 122:38-52. Vajpayee, R. B., N. Mukerji, R. Tandon, N. Sharma, R. M. Pandey, N. R. Biswas, N. Malhotra, and S. A. Melki. 2003. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol 87:1312-1316. van Setten, G. B., L. Viinikka, T. Tervo, K. Pesonen, A. Tarkkanen, and J. Perheentupa. 1989. Epidermal growth factor is a constant component of normal human tear fluid. Graefes Arch Clin Exp Ophthalmol 227:184-187. Wilson, S. E., R. R. Mohan, R. R. Mohan, R. Ambrosio, Jr., J. Hong, and J. Lee. 2001. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res 20:625-637. Yoon, K. C., H. Heo, I. Y. Jeong, and Y. G. Park. 2005. Therapeutic effect of umbilical cord serum eyedrops for persistent corneal epithelial defect. Korean J Ophthalmol 19:174-178. Yoon, K. C., S. K. Im, Y. G. Park, Y. D. Jung, S. Y. Yang, and J. Choi. 2006. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea 25:268-272. Young, A. L., A. C. Cheng, H. K. Ng, L. L. Cheng, G. Y. Leung, and D. S. Lam. 2004. The use of autologous serum tears in persistent corneal epithelial defects. Eye 18:609-614.
|